Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue – CNBC
Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue CNBCLilly expects strong 2024 profit on rising demand for weight-loss drug Yahoo FinanceLilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance | Eli Lilly and Company Investors | Eli Lilly and CompanyLive news: Eli Lilly says diabetes and obesity drugs will boost sales